Please Wait.....
Report
Global Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2023-01-01 I 410 Pages I Data Bridge Market Research
Global throat cancer diagnostics market is projected to register a substantial CAGR of 7.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Global Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others) and By Distribution Channel (Direct Tender and Retail Sales), Country ( U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Rest of Europe, China, Japan, South Korea, India, Thailand, Singapore, Indonesia, Malaysia, Philippines, Australia, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030
- Growing prevalence of throat cancer
- Novel technological advancements in throat cancer diagnostics
Market Players:
Some of the key market players in global throat cancer diagnostics market are listed below:
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific, Inc.
- QIAGEN
- Abbott
- Siemens Healthcare GmbH
- Merck KGAA
- Hologic, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- BIOMERIEUX
- Myriad Genetics, Inc.
- Quest Diagnostics Incorporated.
- Bio-Rad Laboratories, Inc.
- Koninklijke Philips N.V.
- BD
- Time Medical Holding
- PlexBio
- MinFound Medical Systems Co., Ltd
- Medonica Co. LTD
- CANON MEDICAL SYSTEMS CORPORATION
- Sysmex Corporation
- SternMed GmbH
- FUJIFILM Corporation
TABLE OF CONTENTS
1 INTRODUCTION 47
1.1 OBJECTIVES OF THE STUDY 47
1.2 MARKET DEFINITION 47
1.3 OVERVIEW OF THE GLOBAL THROAT CANCER DIAGNOSTICS MARKET 47
1.4 LIMITATIONS 49
1.5 MARKETS COVERED 49
2 MARKET SEGMENTATION 52
2.1 MARKETS COVERED 52
2.2 GEOGRAPHICAL SCOPE 53
2.3 YEARS CONSIDERED FOR THE STUDY 54
2.4 CURRENCY AND PRICING 54
2.5 DBMR TRIPOD DATA VALIDATION MODEL 55
2.6 MULTIVARIATE MODELLING 58
2.7 PRODUCT TYPE LIFELINE CURVE 58
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 59
2.9 DBMR MARKET POSITION GRID 60
2.10 MARKET END USER COVERAGE GRID 61
2.11 VENDOR SHARE ANALYSIS 62
2.12 SECONDARY SOURCES 63
2.13 ASSUMPTIONS 63
3 EXECUTIVE SUMMARY 64
4 PREMIUM INSIGHTS 67
4.1 PESTEL ANALYSIS 70
4.2 PORTER'S FIVE FORCES 71
5 INDUSTRY INSIGHTS 72
6 EPIDEMIOLOGY 73
7 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS 74
7.1 REGULATORY SCENARIO IN THE U.S 74
7.2 REGULATORY SCENARIO IN AUSTRALIA 75
7.3 REGULATORY SCENARIO IN JAPAN 75
7.4 REGULATORY SCENARIO IN CHINA 75
8 MARKET OVERVIEW 77
8.1 DRIVERS 79
8.1.1 GROWING PREVALENCE OF THROAT CANCER 79
8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS 79
8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER 80
8.2 RESTRAINTS 80
8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER 80
8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES. 80
8.3 OPPORTUNITIES 81
8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 81
8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 82
8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 82
8.4 CHALLENGES 83
8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 83
8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 83
9 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 84
9.1 OVERVIEW 85
9.2 INSTRUMENTS 88
9.2.1 PATHOLOGY-BASED INSTRUMENTS 89
9.2.1.1 PCR INSTRUMENTS 89
9.2.1.2 SLIDE STAINING SYSTEMS 89
9.2.1.3 TISSUE PROCESSING SYSTEMS 90
9.2.1.4 CELL PROCESSORS 90
9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 90
9.2.2 IMAGING INSTRUMENTS 90
9.2.2.1 ULTRASOUND SYSTEMS 90
9.2.2.2 CT SYSTEMS 90
9.2.2.3 MRI SYSTEMS 90
9.2.2.4 OTHERS 91
9.2.3 BIOPSY INSTRUMENTS 91
9.2.4 OTHERS 91
9.3 CONSUMABLES & ACCESSORIES 91
9.3.1 KITS 92
9.3.1.1 PCR KITS 92
9.3.1.2 DNA POLYMERASE KITS 92
9.3.1.3 NUCLEIC ACID ISOLATION KITS 92
9.3.1.4 OTHERS 93
9.3.2 REAGENTS 93
9.3.2.1 ASSAYS 93
9.3.2.2 BUFFERS 93
9.3.2.3 PRIMERS 93
9.3.2.4 OTHERS 93
9.3.3 PROBES 93
9.3.4 OTHER CONSUMABLES 93
10 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE 94
10.1 OVERVIEW 95
10.2 IMAGING TEST 98
10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 99
10.2.2 MRI 99
10.2.3 CHEST X-RAY 99
10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 99
10.2.5 OTHERS 99
10.3 BLOOD TEST 99
10.3.1 BLOOD CHEMISTRY TESTS 101
10.3.2 COMPLETE BLOOD COUNT (CBC) 101
10.3.3 OTHERS 101
10.4 BIOPSY 101
10.4.1 ENDOSCOPIC BIOPSY 102
10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY 102
10.4.3 OTHERS 102
10.5 OTHERS 103
11 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 104
11.1 OVERVIEW 105
11.2 PHARYNGEAL CANCER 108
11.2.1 NASOPHARYNGEAL CANCER 109
11.2.2 OROPHARYNGEAL CANCER 109
11.2.3 HYPOPHARYNGEAL CANCER 109
11.3 LARYNGEAL CANCER 110
12 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY STAGES 111
12.1 OVERVIEW 112
12.2 STAGE III 115
12.3 STAGE II 115
12.4 STAGE IV 116
12.5 STAGE I 117
12.6 STAGE 0 118
13 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY AGE 119
13.1 OVERVIEW 120
13.2 30-65 123
13.3 65 AND ABOVE 124
13.4 21-29 124
13.5 BELOW 21 125
14 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY END USER 126
14.1 OVERVIEW 127
14.2 HOSPITALS 130
14.3 ASSOCIATED LABS 130
14.4 INDEPENDENT DIAGNOSTIC LABORATORIES 131
14.5 DIAGNOSTIC IMAGING CENTERS 132
14.6 CANCER RESEARCH INSTITUTES 133
14.7 OTHERS 134
15 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 135
15.1 OVERVIEW 136
15.2 DIRECT TENDER 139
15.3 RETAIL SALES 140
16 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, BY REGION 141
16.1 OVERVIEW 142
16.2 NORTH AMERICA 148
16.2.1 U.S. 158
16.2.2 CANADA 163
16.2.3 MEXICO 168
16.3 EUROPE 173
16.3.1 GERMANY 183
16.3.2 FRANCE 188
16.3.3 U.K. 193
16.3.4 ITALY 198
16.3.5 SPAIN 203
16.3.6 RUSSIA 208
16.3.7 TURKEY 213
16.3.8 NETHERLANDS 218
16.3.9 BELGIUM 223
16.3.10 SWITZERLAND 228
16.3.11 REST OF EUROPE 233
16.4 ASIA-PACIFIC 234
16.4.1 CHINA 245
16.4.2 JAPAN 250
16.4.3 SOUTH KOREA 255
16.4.4 INDIA 260
16.4.5 THAILAND 265
16.4.6 SINGAPORE 270
16.4.7 INDONESIA 275
16.4.8 MALAYSIA 280
16.4.9 PHILIPPINES 285
16.4.10 AUSTRALIA 290
16.4.11 VIETNAM 295
16.4.12 REST OF ASIA-PACIFIC 300
16.5 SOUTH AMERICA 301
16.5.1 BRAZIL 310
16.5.2 ARGENTINA 315
16.5.3 REST OF SOUTH AMERICA 320
16.6 MIDDLE EAST AND AFRICA 321
16.6.1 SAUDI ARABIA 332
16.6.2 U.A.E 337
16.6.3 SOUTH AFRICA 342
16.6.4 EGYPT 347
16.6.5 ISRAEL 352
16.6.6 REST OF MIDDLE EAST AND AFRICA 357
17 GLOBAL THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 358
17.1 COMPANY SHARE ANALYSIS: GLOBAL 358
17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 359
17.3 COMPANY SHARE ANALYSIS: EUROPE 360
17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 361
18 SWOT ANALYSIS 362
19 COMPANY PROFILE 363
19.1 F. HOFFMANN- LA ROCHE LTD 363
19.1.1 COMPANY SNAPSHOT 363
19.1.2 REVENUE ANALYSIS 363
19.1.3 COMPANY SHARE ANALYSIS 364
19.1.4 PRODUCT PORTFOLIO 364
19.1.5 RECENT DEVELOPMENT 364
19.2 FUJIFILM CORPORATION 365
19.2.1 COMPANY SNAPSHOT 365
19.2.2 REVENUE ANALYSIS 365
19.2.3 COMPANY SHARE ANALYSIS 366
19.2.4 PRODUCT PORTFOLIO 366
19.2.5 RECENT DEVELOPMENT 366
19.3 THERMO FISHER SCIENTIFIC INC. 367
19.3.1 COMPANY SNAPSHOT 367
19.3.2 REVENUE ANALYSIS 367
19.3.3 COMPANY SHARE ANALYSIS 368
19.3.4 PRODUCT PORTFOLIO 368
19.3.5 RECENT DEVELOPMENTS 368
19.4 CANON MEDICAL SYSTEMS CORPORATION 369
19.4.1 COMPANY SNAPSHOT 369
19.4.2 REVENUE ANALYSIS 369
19.4.3 COMPANY SHARE ANALYSIS 370
19.4.4 PRODUCT PORTFOLIO 370
19.4.5 RECENT DEVELOPMENT 370
19.5 KONINKLIJKE PHILIPS N.V. 371
19.5.1 COMPANY SNAPSHOT 371
19.5.2 REVENUE ANALYSIS 371
19.5.3 COMPANY SHARE ANALYSIS 372
19.5.4 PRODUCT PORTFOLIO 372
19.5.5 RECENT DEVELOPMENT 373
19.6 ABBOTT 374
19.6.1 COMPANY SNAPSHOT 374
19.6.2 REVENUE ANALYSIS 374
19.6.3 PRODUCT PORTFOLIO 375
19.6.4 RECENT DEVELOPMENTS 375
19.7 AGILENT TECHNOLOGIES, INC. 376
19.7.1 COMPANY SNAPSHOT 376
19.7.2 REVENUE ANALYSIS 376
19.7.3 PRODUCT PORTFOLIO 377
19.7.4 RECENT DEVELOPMENT 377
19.8 BD 378
19.8.1 COMPANY SNAPSHOT 378
19.8.2 REVENUE ANALYSIS 378
19.8.3 PRODUCT PORTFOLIO 379
19.8.4 RECENT DEVELOPMENTS 379
19.9 BEIJING O&D BIOTECH CO., LTD. 380
19.9.1 COMPANY SNAPSHOT 380
19.9.2 PRODUCT PORTFOLIO 380
19.9.3 RECENT DEVELOPMENT 380
19.10 BIO-RAD LABORATORIES, INC. 381
19.10.1 COMPANY SNAPSHOT 381
19.10.2 REVENUE ANALYSIS 381
19.10.3 PRODUCT PORTFOLIO 382
19.10.4 RECENT DEVELOPMENT 382
19.11 FONAR CORP. 383
19.11.1 COMPANY SNAPSHOT 383
19.11.2 REVENUE ANALYSIS 383
19.11.3 PRODUCT PORTFOLIO 384
19.11.4 RECENT DEVELOPMENT 384
19.12 GE HEALTHCARE 385
19.12.1 COMPANY SNAPSHOT 385
19.12.2 REVENUE ANALYSIS 385
19.12.3 PRODUCT PORTFOLIO 386
19.12.4 RECENT DEVELOPMENT 386
19.13 HOLOGIC INC. 387
19.13.1 COMPANY SNAPSHOT 387
19.13.2 REVENUE ANALYSIS 387
19.13.3 PRODUCT PORTFOLIO 388
19.13.4 RECENT DEVELOPMENT 388
19.14 ILLUMINA, INC. 389
19.14.1 COMPANY SNAPSHOT 389
19.14.2 REVENUE ANALYSIS 389
19.14.3 PRODUCT PORTFOLIO 390
19.14.4 RECENT DEVELOPMENT 390
19.15 MEDONICA CO. LTD 391
19.15.1 COMPANY SNAPSHOT 391
19.15.2 PRODUCT PORTFOLIO 391
19.15.3 RECENT DEVELOPMENT 391
19.16 MERCK KGAA 392
19.16.1 COMPANY SNAPSHOT 392
19.16.2 REVENUE ANALYSIS 392
19.16.3 PRODUCT PORTFOLIO 393
19.16.4 RECENT DEVELOPMENT 393
19.17 MINFOUND MEDICAL SYSTEMS CO., LTD 394
19.17.1 COMPANY SNAPSHOT 394
19.17.2 PRODUCT PORTFOLIO 394
19.17.3 RECENT DEVELOPMENT 394
19.18 MYRIAD GENETICS, INC. 395
19.18.1 COMPANY SNAPSHOT 395
19.18.2 REVENUE ANALYSIS 395
19.18.3 PRODUCT PORTFOLIO 396
19.18.4 RECENT DEVELOPMENT 396
19.19 PLEXBIO 397
19.19.1 COMPANY SNAPSHOT 397
19.19.2 PRODUCT PORTFOLIO 397
19.19.3 RECENT DEVELOPMENT 397
19.20 QIAGEN 398
19.20.1 COMPANY SNAPSHOT 398
19.20.2 REVENUE ANALYSIS 398
19.20.3 PRODUCT PORTFOLIO 399
19.20.4 RECENT DEVELOPMENT 399
19.21 QUEST DIAGNOSTICS INCORPORATED 400
19.21.1 COMPANY SNAPSHOT 400
19.21.2 REVENUE ANALYSIS 400
19.21.3 PRODUCT PORTFOLIO 401
19.21.4 RECENT DEVELOPMENT 401
19.22 SIEMENS HEALTHCARE GMBH 402
19.22.1 COMPANY SNAPSHOT 402
19.22.2 REVENUE ANALYSIS 402
19.22.3 PRODUCT PORTFOLIO 403
19.22.4 RECENT DEVELOPMENT 403
19.23 STERNMED GMBH 404
19.23.1 COMPANY SNAPSHOT 404
19.23.2 PRODUCT PORTFOLIO 404
19.23.3 RECENT DEVELOPMENT 404
19.24 TIME MEDICAL HOLDING. 405
19.24.1 COMPANY SNAPSHOT 405
19.24.2 PRODUCT PORTFOLIO 405
19.24.3 RECENT DEVELOPMENT 405
20 QUESTIONNAIRE 406
21 RELATED REPORTS 410
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security